Here, we show for the first time that NFATC1, a key regulator of inflammatory responses [23], potently synergizes with FLT3ITD, by causing stem cell expansion rather stem cell depletion, resulting in the development of a FLT3-kinase inhibitor-resistant lethal AML. Here, FLT3 is linked to acute myeloid leukemia.